4 Kingdom Street
Floor 4 Unit 4B Paddington Central
London W2 6BD
United Kingdom
44 20 4551 8888
https://www.etherapeutics.co.uk
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 34
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Ahmad Ali Mortazavi | CEO & Director | 270k | N/A | 1971 |
Mr. Timothy Bretherton | CFO, Director of Finance & Operations and Company Secretary | N/A | N/A | N/A |
Dr. Laura Roca-Alonso Ph.D. | Chief Operating & Business Officer | N/A | N/A | N/A |
Mr. Alan Whitmore B.Sc., Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
Mr. Ankit Sharma | Head of Software Engineering | N/A | N/A | N/A |
Mr. Graham Craggs | Head of Therapeutic Discovery | N/A | N/A | N/A |
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet. The company was incorporated in 2001 and is based in London, the United Kingdom.
e-therapeutics plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.